A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions

Launched by NEUROPTEK CORPORATION INC. · Mar 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new device called EyeMirage that helps test eye function, comparing it to the standard methods currently used in eye clinics. The goal is to see how well the new device works in assessing various aspects of vision, such as clarity of sight, color perception, and eye movement. Participants will take four eye tests using both the EyeMirage and the standard devices during a single visit to the eye clinic.

To be eligible for the study, participants need to be between 18 and 65 years old and have good vision (20/200 or better). They should also be willing to follow the study procedures, which include eye assessments and a follow-up call 30 days after the tests to check in and address any concerns. However, individuals with certain vision problems or specific medical conditions, such as severe cognitive or motor diseases, will not be able to participate. This study aims to improve eye testing methods, and participants will play an important role in helping researchers understand how effective this new device can be.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Evidence of a signed and dated informed consent document confirming that the participant has been informed of all aspects of the clinical study.
• • Male or female participants, 18 to 65 years of age at time of screening.
• • Visual acuity of 20/200 or better.
• • Willingness to comply with required screening procedures, eye assessments, and follow-up visits, if needed.
• Exclusion Criteria:
• • Visual acuity worse than 20/200 in either eye
• • Complete blindness or diffuse vision loss in either eye
• * Clinical diagnosis of cognitive and motor diseases including but not limited to the following:
• • 1. Neurodegenerative diseases such as dementia-like Alzheimer's disease, posterior cortical atrophy
• • 2. Movement disorders such as Parkinson's disease and Parkinsonism tremors
• • 3. Multiple sclerosis, stroke or any other neurological or physical conditions with paresis or plegia (i.e. weakness or paralysis of the limbs)
• • Eyes with a spherical equivalent of greater than +9 or -9 diopters where the corrective lens is too large to fit in the headset.